AccScience Publishing / GTM / Volume 3 / Issue 2 / DOI: 10.36922/gtm.3678
EDITORIAL

Omicron or no longer omicron: That is the question

Giuseppe Lippi1*
Show Less
1 Department of Engineering for Innovative Medicine, Section of Clinical Biochemistry, Faculty of Medicine, University of Verona, Verona, Italy
Global Translational Medicine 2024, 3(2), 3678 https://doi.org/10.36922/gtm.3678
Submitted: 15 May 2024 | Published: 10 June 2024
© 2024 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
References
  1. Bose M, Munshi C. Comparative analysis of immune responses in humans infected with Alpha, Delta, and Omicron strains of SARS-CoV-2. Glob Transl Med. 2024;3:2228. doi: 10.36922/gtm.2228

 

  1. Wang X, Lu L, Jiang S. SARS-CoV-2 evolution from the BA.2.86 to JN.1 variants: Unexpected consequences. Trends Immunol. 2024;45(2):81-84. doi: 10.1016/j.it.2024.01.003

 

  1. Li P, Liu Y, Faraone JN, et al. Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion. mBio. 2024;15(5): e0075124. doi: 10.1128/mbio.00751-24
Conflict of interest
The author declares no conflicts of interest.
Share
Back to top
Global Translational Medicine, Electronic ISSN: 2811-0021 Published by AccScience Publishing